Literature DB >> 20406893

Gliomas display a microRNA expression profile reminiscent of neural precursor cells.

Iris Lavon1, Daniel Zrihan, Avital Granit, Ofira Einstein, Nina Fainstein, Malkiel A Cohen, Mikhal A Cohen, Bracha Zelikovitch, Yigal Shoshan, Sergei Spektor, Benjamin E Reubinoff, Yakov Felig, Offer Gerlitz, Tamir Ben-Hur, Yohav Smith, Tali Siegal.   

Abstract

Gliomas express many genes that play a role in neural precursor cells (NPCs), but no direct comparison between glioma and stem cell (SC) gene expression profiles has been performed. To investigate the similarities and differences between gliomas and SCs, we compared the microRNA (miRNA) expression signatures of glial tumors, embryonic SCs (ESCs), NPCs, and normal adult brains from both human and mouse tissues. We demonstrated that both human gliomas (regardless of their grade) and methylcholanthrene-induced mouse glioma shared an miRNA expression profile that is reminiscent of NPCs. About half of the miRNAs expressed in the shared profile clustered in seven genomic regions susceptible to genetic/epigenetic alterations in various cancers. These clusters comprised the miR17 family, mir183-182, and the SC-specific clusters mir367-302 and mir371-373, which are upregulated in gliomas, ESCs, and NPCs. The bipartite cluster of 7 + 46 miRNAs on chromosome 14q32.31, which might represent the largest tumor suppressor miRNA cluster, was downregulated in the shared expression profile. This study provides the first evidence for association between these clusters and gliomas. Despite the broad similarity in the miRNA expression profiles, 15 miRNAs showed disparate expression between SC and gliomas. Ten miRNAs belong to the 2 SC-specific clusters and the remaining (mir135b, mir141, mir205, mir200C, and mir301a) have been previously shown to associate with malignancies. Our finding showed that all gliomas displayed NPC-like miRNA signatures, which may have implications for studies of glioma origins. Furthermore, careful study of the 15 miRNAs that differ in expression between SCs and gliomas, particularly those 5 that are not SC-specific, may enhance our understanding of gliomagenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20406893      PMCID: PMC2940621          DOI: 10.1093/neuonc/nop061

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  49 in total

1.  DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours.

Authors:  J Felsberg; P S Yan; T H-M Huang; U Milde; J Schramm; O D Wiestler; G Reifenberger; T Pietsch; A Waha
Journal:  Neuropathol Appl Neurobiol       Date:  2006-10       Impact factor: 8.090

Review 2.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

Authors:  George A Calin; Carlo M Croce
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma.

Authors:  Sophie Gazzo; Ilse Chudoba; Alexandra Traverse-Glehen; Lucile Baseggio; Pascale Felman; Françoise Berger; Gilles Salles; Sandrine Hayette; Jean-Pierre Magaud; Evelyne Callet-Bauchu
Journal:  Cancer Genet Cytogenet       Date:  2007-06

4.  Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research.

Authors:  Richard Josephson; Carol J Ording; Ying Liu; Soojung Shin; Uma Lakshmipathy; Araz Toumadje; Bradley Love; Jonathan D Chesnut; Peter W Andrews; Mahendra S Rao; Jonathan M Auerbach
Journal:  Stem Cells       Date:  2007-02       Impact factor: 6.277

5.  Nonrestrictive developmental regulation of microRNA gene expression.

Authors:  William M Strauss; Caifu Chen; Chung-Tien Lee; Dana Ridzon
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

6.  Human microRNA clusters: genomic organization and expression profile in leukemia cell lines.

Authors:  Jia Yu; Fang Wang; Gui-Hua Yang; Fan-Long Wang; Yan-Ni Ma; Zhan-Wen Du; Jun-Wu Zhang
Journal:  Biochem Biophys Res Commun       Date:  2006-08-11       Impact factor: 3.575

7.  Expression profiling identifies microRNA signature in pancreatic cancer.

Authors:  Eun Joo Lee; Yuriy Gusev; Jinmai Jiang; Gerard J Nuovo; Megan R Lerner; Wendy L Frankel; Daniel L Morgan; Russell G Postier; Daniel J Brackett; Thomas D Schmittgen
Journal:  Int J Cancer       Date:  2007-03-01       Impact factor: 7.396

8.  MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.

Authors:  Takashi Sasayama; Masamitsu Nishihara; Takeshi Kondoh; Kohkichi Hosoda; Eiji Kohmura
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

Review 9.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene.

Authors:  Koji Aoki; Makoto M Taketo
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

10.  Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets.

Authors:  Caifu Chen; Dana Ridzon; Chung-Tien Lee; Julie Blake; Yongming Sun; William M Strauss
Journal:  Mamm Genome       Date:  2007-07-03       Impact factor: 2.957

View more
  66 in total

1.  Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.

Authors:  Friedrich Erhart; Matthias Hackl; Hannes Hahne; Johanna Buchroithner; Chen Meng; Simone Klingenbrunner; René Reitermaier; Katrin Fischhuber; Susanna Skalicky; Walter Berger; Sabine Spiegl-Kreinecker; Daniela Lötsch; Gerda Ricken; Bernhard Kuster; Adelheid Wöhrer; Georg Widhalm; Johannes Hainfellner; Thomas Felzmann; Alexander M Dohnal; Christine Marosi; Carmen Visus
Journal:  NPJ Vaccines       Date:  2020-01-16       Impact factor: 7.344

Review 2.  MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.

Authors:  Pilar González-Gómez; Pilar Sánchez; Helena Mira
Journal:  Mol Neurobiol       Date:  2011-07-05       Impact factor: 5.590

3.  MicroRNA-146a inhibits glioma development by targeting Notch1.

Authors:  Jie Mei; Robert Bachoo; Chun-Li Zhang
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

Review 4.  MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells.

Authors:  Jeffrey V Brower; Paul A Clark; Will Lyon; John S Kuo
Journal:  Neurochem Int       Date:  2014-06-14       Impact factor: 3.921

Review 5.  MicroRNA as potential biomarkers in Glioblastoma.

Authors:  Zammam Areeb; Stanley S Stylli; Rachel Koldej; David S Ritchie; Tali Siegal; Andrew P Morokoff; Andrew H Kaye; Rodney B Luwor
Journal:  J Neurooncol       Date:  2015-09-21       Impact factor: 4.130

6.  MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.

Authors:  Rui-Qing Tian; Xing-Hua Wang; Li-Juan Hou; Wei-Hua Jia; Qian Yang; Yi-Xuan Li; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

Review 7.  Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.

Authors:  Agnieszka Bronisz; Jakub Godlewski; E Antonio Chiocca
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

8.  Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.

Authors:  Tal Shahar; Avital Granit; Daniel Zrihan; Tamar Canello; Hanna Charbit; Ofira Einstein; Uri Rozovski; Sharona Elgavish; Zvi Ram; Tali Siegal; Iris Lavon
Journal:  J Neurooncol       Date:  2016-08-29       Impact factor: 4.130

9.  Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.

Authors:  Hiroaki Uchida; Marco Marzulli; Kenji Nakano; William F Goins; Janet Chan; Chang-Sook Hong; Lucia Mazzacurati; Ji Young Yoo; Amy Haseley; Hiroshi Nakashima; Hyunjung Baek; Heechung Kwon; Izumi Kumagai; Masahide Kuroki; Balveen Kaur; E Antonio Chiocca; Paola Grandi; Justus B Cohen; Joseph C Glorioso
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

Review 10.  MicroRNA biomarkers in glioblastoma.

Authors:  Simon Kjær Hermansen; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2013-05-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.